Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Worldwide Stock Indices Sample helps you grasp how global benchmarks reflect market trends. This intro explains key components and practical uses in everyday investing.
16,517 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Two AI-driven stocks are at the forefront of the tech shift. This guide explains how they shape future technology, wh...
NASA issued a comprehensive review of Boeing's Starliner program, yet the agency has not pulled the plug. Here’s how ...
Fans and investors alike crave clarity on Funko's 2025 earnings. This guide breaks down revenue streams, margin dynam...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
A notorious short-seller unloaded sofi this week with sweeping accusations, but the stock shrugged off most of the blow.
SpaceX may steal headlines, but the real action for investors is in the earnings reports of BlackSky, Redwire, and Ro...
Barclays slashed Coinbase’s price target to $107 following aQ1 2026 revenue miss, highlighting a tug-of-war between c...
Investors are keen on LENZ as the company reports Q1 2026 earnings. This in-depth look breaks down the key numbers, w...
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
Cerebras Systems jumped after its IPO, but is it too late to join the rally? This guide breaks down the tech, market ...
USA Rare Earth stock jumped today as traders weighed supply chain risks and policy signals. Here’s a closer look at w...